Home » Posts tagged 'Evan Reinblatt (IPilogue Editor)'

Evan Reinblatt (IPilogue Editor)

Colourful Rubik’s Cube description leaves public ‘confused’ and ‘scratching their heads’: EU Court of Justice

Colourful Rubik’s Cube description leaves public ‘confused’ and ‘scratching their heads’: EU Court of Justice

“Six surfaces being geometrically arranged in three pairs of parallel surfaces, with each pair being arranged perpendicularly to the other two pairs characterised by: (i) any two adjacent surfaces having different colours and (ii) each such surface having a grid structure formed by black borders dividing the surface into nine equal segments”.

Message Delivered, But Not Received: BBM Canada Loses Case Against RIM

Message Delivered, But Not Received: BBM Canada Loses Case Against RIM

When hearing the word BBM, most people reach instinctively for their BlackBerry, and its instant messaging service, BlackBerry Messenger. However, there is also a company called BBM Canada, formerly known as the Bureau of Broadcast Measurement, which provides impartial ratings data and analysis to Canadian broadcasters and advertisers. BBM Canada sued Research in Motion (“RIM”), […]

Not-so-Fair Dealing: How Access Copyright is Limiting Access to Copyrighted Materials

Not-so-Fair Dealing: How Access Copyright is Limiting Access to Copyrighted Materials

In light of the recent Quebec student protests (see here), and the support that the protests are gaining nationwide, one might suspect that there would be a general trend towards cheaper education in Canada. However, two recent cases suggest that while that may be the case in the U.S., the same may not be true […]

Servier v Apotex: Illegality Earns $17.5 Million in Damages

Servier v Apotex: Illegality Earns $17.5 Million in Damages

Normally, doing something that breaks the law earns you a punishment, including a fine, community service, or even imprisonment. However, when Apotex Inc., a large generic pharmaceutical company, began producing and selling a drug that Servier Laboratories Limited, another large pharmaceutical company, had patented, Apotex was awarded $17.5 million.